These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 377743)

  • 1. [Estradiol and estriol in the treatment of climacteric symptoms. A controlled trial].
    Bennedsen H; Nielsen JV
    Ugeskr Laeger; 1979 May; 141(22):1471-7. PubMed ID: 377743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
    Serup J; Bostofte E; Larsen S; Westergaard J
    Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peroral treatment with natural human estrogens in the climacteric].
    Sele V; Obel E
    Ugeskr Laeger; 1980 Sep; 142(38):2497-500. PubMed ID: 7445154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
    Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New preparations for treatment of climacterial disorders].
    Nesheim BI
    Tidsskr Nor Laegeforen; 1979 May; 99(15):792-3. PubMed ID: 462446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal treatment of climacteric complaints. A controlled, double-blind comparative study between 2 different types of sequential estrogen-gestagen preparations].
    Gam F; Helles A; Andersen B
    Ugeskr Laeger; 1977 Nov; 139(47):2808-12. PubMed ID: 339455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestriol succinate in the treatment of climacteric women (a double-blind trial).
    Järvinen PA; Kokkonen J; Ryhänen P
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:26. PubMed ID: 4941231
    [No Abstract]   [Full Text] [Related]  

  • 14. Does adding estrogen to the hormone-free days of an oral contraceptive (OC) cycle reduce menopausal symptoms in perimenopausal OC users?
    Bielanski TE
    J Fam Pract; 2001 Oct; 50(10):838. PubMed ID: 11674879
    [No Abstract]   [Full Text] [Related]  

  • 15. [Estrogens treatment in the climacteric].
    Lebech PE
    Nord Med; 1977 May; 92(5):146-7. PubMed ID: 866103
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood lipids and the clinical state of hormone-treated women during menopause].
    Dominiczak-Gawrońska M
    Ann Acad Med Stetin; 1989; 35():145-66. PubMed ID: 2484147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention and treatment of mental disorders in women during the climacteric period].
    Tiushina NA; Balabanova VV; Balan VE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):79-82. PubMed ID: 1664621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transdermal estrogen treatment. A placebo controlled study].
    Iversen OE; Eid AB; Johannesen KH; Nyland B; Løvset T
    Tidsskr Nor Laegeforen; 1991 Aug; 111(20):2544-6. PubMed ID: 1948834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.